StocksDeepDive
Snapshot · Foreign US-listed · generated 2026-11-11 20:45 UTC

FMS — Fresenius Medical Care AG

UNDERVALUED (MOS Model unreliable) · Quality 54/100

Price
22.31
Intrinsic value
99.72
Margin of safety
Model unreliable
Implied growth (reverse DCF)
-12.1%
model assumes +10.1%
Value Score
40.9
Quality
54
Psychology
6.4
Discovery
39.1
price/volume attention only
Moat score
48
erosion: none

Value Score: top 34% of Foreign US-listed · Quality: bottom 30%

Dividend: 0.872/share (TTM) · yield 3.9% · payout 51%

Open the interactive Deep Dive for FMS →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/FMS - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is FMS undervalued?

As of 2026-11-11, FMS trades at 22.31 against a computed intrinsic value of 99.72 (+77.6% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Fresenius Medical Care AG's Value Score?

Fresenius Medical Care AG's Value Score is 40.9 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.

Does FMS pay a dividend?

Yes - FMS's trailing twelve-month dividend is 0.872/share, a yield of 3.9% at the current price (as of 2026-11-11).